Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has issued an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company announced that its subsidiary, Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd., received approval from the Guangdong Provincial Drug Administration for changes to its ‘Drug Production License’. The approval allows the subsidiary to reduce its production scope, workshops, and production lines, which could streamline operations and potentially impact its manufacturing efficiency and cost structure.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company operates in the pharmaceutical industry, focusing on the production and distribution of various medications, including tablets, capsules, and injections. The company is known for its extensive range of pharmaceutical products and its market presence in China.
YTD Price Performance: 3.49%
Average Trading Volume: 30,548
Technical Sentiment Signal: Buy
Current Market Cap: $5.52B
See more data about 0874 stock on TipRanks’ Stock Analysis page.